ALEXANDER KOKOLUS: Open Payments
NPI 1558037408 · BOWMANSTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,130 in 56 payments from 8 companies in 2025. Trend: 2023 $219 · 2024 $325 · 2025 $1,130
Food & beverage: $1,130
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 9 | $262 |
| Teva Pharmaceuticals USA, Inc. | 16 | $260 |
| E.R. Squibb & Sons, L.L.C. | 7 | $162 |
| Lundbeck LLC | 11 | $140 |
| Alkermes, Inc. | 5 | $121 |
| Otsuka America Pharmaceutical, Inc. | 3 | $74 |
| Janssen Pharmaceuticals, Inc | 3 | $70 |
| Sage Therapeutics, LLC | 2 | $40 |
Products named: INGREZZA, UZEDY, COBENFY, REXULTI, ARISTADA, AUSTEDO XR, SPRAVATO, ABILIFY ASIMTUFII.
Industry payments across PA — which companies pay providers there.
